Immunomodulatory potential of Nisin A with application in wound healing
Antimicrobial peptides can have a dual role with both antimicrobial activity against a broad range of bacteria and immunomodulatory effect, making them attractive as therapeutic treatment of difficult wounds. Nisin A is widely known for its antimicrobial activity, and a preliminary study demonstrate...
Saved in:
Published in | Wound repair and regeneration Vol. 27; no. 6; pp. 650 - 660 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.11.2019
|
Online Access | Get full text |
ISSN | 1067-1927 1524-475X 1524-475X |
DOI | 10.1111/wrr.12743 |
Cover
Abstract | Antimicrobial peptides can have a dual role with both antimicrobial activity against a broad range of bacteria and immunomodulatory effect, making them attractive as therapeutic treatment of difficult wounds. Nisin A is widely known for its antimicrobial activity, and a preliminary study demonstrated that it increased wound closure, but the mechanism behind its effect is unknown. The aim of this study is to elucidate the wound healing potential of Nisin A and the mechanism behind. First, an epithelial and endothelial cell line, human keratinocyte (HaCaT) and human umbilical vein endothelial cell, were used to demonstrate migration and proliferation effects in vitro. From HaCaT cells and peripheral blood mononuclear cell, changes in cytokine levels were shown by quantitative polymerase chain reaction and enzyme‐linked immunosorbent assay. Second, the ex vivo porcine wound healing model was used to investigate the re‐epithelization potential of Nisin A. Finally, the model Galleria mellonella was used to confirm antimicrobial activity and to investigate potential immunomodulatory effects in vivo. Here, we demonstrated that Nisin A affected migration significantly of both human umbilical vein endothelial cell and HaCaT cells (p < 0.05) but not proliferation, potentially by decreasing the levels of proinflammatory cytokines tumor necrosis factor‐α, interleukin‐6, and interleukin‐8 (p < 0.001). Furthermore, Nisin A treatment diminished lipopolysaccharide‐induced tumor necrosis factor‐α levels from peripheral blood mononuclear cells and monocyte chemoattractant protein‐1 from HaCaT cells (p < 0.001). Furthermore, Nisin A did not affect proliferation ex vivo either but increased re‐epithelization of the porcine skin. Nisin A improved survival of G. mellonella significantly from Staphylococcus epidermidis (p < 0.001) but not from Escherichia coli, indicating that Nisin A did not help the larvae to survive the infection in a different than direct antimicrobial way. All together this makes Nisin A a potential treatment to use in wound healing, as it increases the mobility of skin cells, dampens the effect of lipopolysaccharide and proinflammatory cytokines, and decreases bacterial growth. |
---|---|
AbstractList | Antimicrobial peptides can have a dual role with both antimicrobial activity against a broad range of bacteria and immunomodulatory effect, making them attractive as therapeutic treatment of difficult wounds. Nisin A is widely known for its antimicrobial activity, and a preliminary study demonstrated that it increased wound closure, but the mechanism behind its effect is unknown. The aim of this study is to elucidate the wound healing potential of Nisin A and the mechanism behind. First, an epithelial and endothelial cell line, human keratinocyte (HaCaT) and human umbilical vein endothelial cell, were used to demonstrate migration and proliferation effects in vitro. From HaCaT cells and peripheral blood mononuclear cell, changes in cytokine levels were shown by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay. Second, the ex vivo porcine wound healing model was used to investigate the re-epithelization potential of Nisin A. Finally, the model Galleria mellonella was used to confirm antimicrobial activity and to investigate potential immunomodulatory effects in vivo. Here, we demonstrated that Nisin A affected migration significantly of both human umbilical vein endothelial cell and HaCaT cells (p < 0.05) but not proliferation, potentially by decreasing the levels of proinflammatory cytokines tumor necrosis factor-α, interleukin-6, and interleukin-8 (p < 0.001). Furthermore, Nisin A treatment diminished lipopolysaccharide-induced tumor necrosis factor-α levels from peripheral blood mononuclear cells and monocyte chemoattractant protein-1 from HaCaT cells (p < 0.001). Furthermore, Nisin A did not affect proliferation ex vivo either but increased re-epithelization of the porcine skin. Nisin A improved survival of G. mellonella significantly from Staphylococcus epidermidis (p < 0.001) but not from Escherichia coli, indicating that Nisin A did not help the larvae to survive the infection in a different than direct antimicrobial way. All together this makes Nisin A a potential treatment to use in wound healing, as it increases the mobility of skin cells, dampens the effect of lipopolysaccharide and proinflammatory cytokines, and decreases bacterial growth.Antimicrobial peptides can have a dual role with both antimicrobial activity against a broad range of bacteria and immunomodulatory effect, making them attractive as therapeutic treatment of difficult wounds. Nisin A is widely known for its antimicrobial activity, and a preliminary study demonstrated that it increased wound closure, but the mechanism behind its effect is unknown. The aim of this study is to elucidate the wound healing potential of Nisin A and the mechanism behind. First, an epithelial and endothelial cell line, human keratinocyte (HaCaT) and human umbilical vein endothelial cell, were used to demonstrate migration and proliferation effects in vitro. From HaCaT cells and peripheral blood mononuclear cell, changes in cytokine levels were shown by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay. Second, the ex vivo porcine wound healing model was used to investigate the re-epithelization potential of Nisin A. Finally, the model Galleria mellonella was used to confirm antimicrobial activity and to investigate potential immunomodulatory effects in vivo. Here, we demonstrated that Nisin A affected migration significantly of both human umbilical vein endothelial cell and HaCaT cells (p < 0.05) but not proliferation, potentially by decreasing the levels of proinflammatory cytokines tumor necrosis factor-α, interleukin-6, and interleukin-8 (p < 0.001). Furthermore, Nisin A treatment diminished lipopolysaccharide-induced tumor necrosis factor-α levels from peripheral blood mononuclear cells and monocyte chemoattractant protein-1 from HaCaT cells (p < 0.001). Furthermore, Nisin A did not affect proliferation ex vivo either but increased re-epithelization of the porcine skin. Nisin A improved survival of G. mellonella significantly from Staphylococcus epidermidis (p < 0.001) but not from Escherichia coli, indicating that Nisin A did not help the larvae to survive the infection in a different than direct antimicrobial way. All together this makes Nisin A a potential treatment to use in wound healing, as it increases the mobility of skin cells, dampens the effect of lipopolysaccharide and proinflammatory cytokines, and decreases bacterial growth. Antimicrobial peptides can have a dual role with both antimicrobial activity against a broad range of bacteria and immunomodulatory effect, making them attractive as therapeutic treatment of difficult wounds. Nisin A is widely known for its antimicrobial activity, and a preliminary study demonstrated that it increased wound closure, but the mechanism behind its effect is unknown. The aim of this study is to elucidate the wound healing potential of Nisin A and the mechanism behind. First, an epithelial and endothelial cell line, human keratinocyte (HaCaT) and human umbilical vein endothelial cell, were used to demonstrate migration and proliferation effects in vitro. From HaCaT cells and peripheral blood mononuclear cell, changes in cytokine levels were shown by quantitative polymerase chain reaction and enzyme‐linked immunosorbent assay. Second, the ex vivo porcine wound healing model was used to investigate the re‐epithelization potential of Nisin A. Finally, the model Galleria mellonella was used to confirm antimicrobial activity and to investigate potential immunomodulatory effects in vivo. Here, we demonstrated that Nisin A affected migration significantly of both human umbilical vein endothelial cell and HaCaT cells ( p < 0.05) but not proliferation, potentially by decreasing the levels of proinflammatory cytokines tumor necrosis factor‐α, interleukin‐6, and interleukin‐8 ( p < 0.001). Furthermore, Nisin A treatment diminished lipopolysaccharide‐induced tumor necrosis factor‐α levels from peripheral blood mononuclear cells and monocyte chemoattractant protein‐1 from HaCaT cells ( p < 0.001). Furthermore, Nisin A did not affect proliferation ex vivo either but increased re‐epithelization of the porcine skin. Nisin A improved survival of G. mellonella significantly from Staphylococcus epidermidis ( p < 0.001) but not from Escherichia coli , indicating that Nisin A did not help the larvae to survive the infection in a different than direct antimicrobial way. All together this makes Nisin A a potential treatment to use in wound healing, as it increases the mobility of skin cells, dampens the effect of lipopolysaccharide and proinflammatory cytokines, and decreases bacterial growth. Antimicrobial peptides can have a dual role with both antimicrobial activity against a broad range of bacteria and immunomodulatory effect, making them attractive as therapeutic treatment of difficult wounds. Nisin A is widely known for its antimicrobial activity, and a preliminary study demonstrated that it increased wound closure, but the mechanism behind its effect is unknown. The aim of this study is to elucidate the wound healing potential of Nisin A and the mechanism behind. First, an epithelial and endothelial cell line, human keratinocyte (HaCaT) and human umbilical vein endothelial cell, were used to demonstrate migration and proliferation effects in vitro. From HaCaT cells and peripheral blood mononuclear cell, changes in cytokine levels were shown by quantitative polymerase chain reaction and enzyme‐linked immunosorbent assay. Second, the ex vivo porcine wound healing model was used to investigate the re‐epithelization potential of Nisin A. Finally, the model Galleria mellonella was used to confirm antimicrobial activity and to investigate potential immunomodulatory effects in vivo. Here, we demonstrated that Nisin A affected migration significantly of both human umbilical vein endothelial cell and HaCaT cells (p < 0.05) but not proliferation, potentially by decreasing the levels of proinflammatory cytokines tumor necrosis factor‐α, interleukin‐6, and interleukin‐8 (p < 0.001). Furthermore, Nisin A treatment diminished lipopolysaccharide‐induced tumor necrosis factor‐α levels from peripheral blood mononuclear cells and monocyte chemoattractant protein‐1 from HaCaT cells (p < 0.001). Furthermore, Nisin A did not affect proliferation ex vivo either but increased re‐epithelization of the porcine skin. Nisin A improved survival of G. mellonella significantly from Staphylococcus epidermidis (p < 0.001) but not from Escherichia coli, indicating that Nisin A did not help the larvae to survive the infection in a different than direct antimicrobial way. All together this makes Nisin A a potential treatment to use in wound healing, as it increases the mobility of skin cells, dampens the effect of lipopolysaccharide and proinflammatory cytokines, and decreases bacterial growth. |
Author | Andrea, Athina Poulsen, Steen S. Mouritzen, Michelle V. Jenssen, Håvard Qvist, Katrine |
Author_xml | – sequence: 1 givenname: Michelle V. orcidid: 0000-0003-3870-5113 surname: Mouritzen fullname: Mouritzen, Michelle V. organization: Roskilde University – sequence: 2 givenname: Athina surname: Andrea fullname: Andrea, Athina organization: Roskilde University – sequence: 3 givenname: Katrine surname: Qvist fullname: Qvist, Katrine organization: Roskilde University – sequence: 4 givenname: Steen S. surname: Poulsen fullname: Poulsen, Steen S. organization: University of Copenhagen – sequence: 5 givenname: Håvard orcidid: 0000-0003-0007-0335 surname: Jenssen fullname: Jenssen, Håvard email: jenssen@ruc.dk organization: Roskilde University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31287619$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kN9LwzAQx4NM3A998B-QPupDt6RN2uVxDJ2DoTAUfSvXLHWRNKlJS9l_b92mD4Leyx3H53twnyHqGWskQpcEj0lXk9a5MYlSGp-gAWERDWnKXnvdjJM0JDxK-2jo_TvGmDE-PUP9mETTNCF8gBbLsmyMLe2m0VBbtwsqW0tTK9CBLYIH5ZUJZkGr6m0AVaWVgFpZE3Tb1jZmE2wlaGXeztFpAdrLi2Mfoee726f5fbh6XCzns1Uo4ojFYS4o5HmMIc0p4QBcME5kwZkgQoIACjLmnElJaExxSjFlES4KMpUCSAFJPELXh7uVsx-N9HVWKi-k1mCkbXwWRYwyklCOO_TqiDZ5KTdZ5VQJbpd9P98BNwdAOOu9k8UPQnD2JTbrxGZ7sR07-cUKVe9V1A6U_i_RKi13f5_OXtbrQ-ITckaKOw |
CitedBy_id | crossref_primary_10_12968_jowc_2023_32_5_318 crossref_primary_10_1007_s10989_022_10452_8 crossref_primary_10_3390_pharmaceutics14122716 crossref_primary_10_3390_biom11070952 crossref_primary_10_3390_polym15244701 crossref_primary_10_3168_jds_2021_21356 crossref_primary_10_1016_j_omtm_2021_02_008 crossref_primary_10_1039_D4NP00042K crossref_primary_10_3390_antibiotics13010049 crossref_primary_10_1155_2021_5518825 crossref_primary_10_1186_s12917_024_04105_9 crossref_primary_10_3390_antibiotics12010141 crossref_primary_10_1016_j_peptides_2021_170707 crossref_primary_10_3390_antibiotics9060305 crossref_primary_10_1155_2022_2914210 crossref_primary_10_5851_kosfa_2023_e34 crossref_primary_10_5115_acb_21_168 crossref_primary_10_1016_j_jddst_2023_105246 crossref_primary_10_3390_foods11111575 crossref_primary_10_1007_s00203_024_04152_8 crossref_primary_10_1016_j_carpta_2025_100762 crossref_primary_10_1016_j_ijbiomac_2024_131329 crossref_primary_10_1111_wrr_12909 crossref_primary_10_1002_jobm_202400510 crossref_primary_10_1016_j_peptides_2024_171220 crossref_primary_10_1007_s00203_024_03948_y crossref_primary_10_1016_j_heliyon_2025_e42510 crossref_primary_10_1016_j_peptides_2020_170479 crossref_primary_10_1007_s12223_022_01030_y crossref_primary_10_1016_j_bpc_2021_106603 crossref_primary_10_3390_fermentation8060255 crossref_primary_10_34172_apb_2022_047 crossref_primary_10_3390_nu13124265 crossref_primary_10_1016_j_jconrel_2023_08_061 crossref_primary_10_3390_pharmaceutics14010076 crossref_primary_10_3390_ijms23010321 crossref_primary_10_1016_j_pharmthera_2021_107990 crossref_primary_10_3390_membranes12121253 crossref_primary_10_1093_jac_dkab040 |
Cites_doi | 10.1128/AAC.00622-13 10.3892/etm.2011.402 10.1089/adt.2014.573 10.1089/wound.2012.0381 10.1016/S0378-5173(00)00665-7 10.1242/jcs.079509 10.1002/psc.3093 10.1007/s12602-013-9141-3 10.1016/j.ijpharm.2017.04.071 10.1002/psc.1341 10.1002/psc.3080 10.1016/S0928-8244(99)00004-8 10.3390/microorganisms7030085 10.1007/s00018-011-0710-x 10.12703/P6-13 10.1155/2017/7435621 10.1093/ilar/ilv016 10.3389/fmicb.2015.00617 10.1046/j.1469-7580.1997.19040601.x 10.1038/nprot.2008.73 10.1038/nrm1619 10.1016/j.it.2018.01.010 10.1186/1471-2180-13-23 10.1128/AAC.00888-13 10.1165/rcmb.2009-0250OC 10.1159/000336630 10.1189/jlb.0802397 10.1126/scitranslmed.3009337 10.1016/j.det.2007.06.003 10.1089/wound.2015.0635 10.1093/jac/dkf190 10.1016/j.peptides.2018.01.010 10.1038/srep11458 10.1096/fj.01-0776com 10.1371/journal.pone.0184164 10.1371/journal.pone.0131008 10.1177/1753425912461456 10.1111/j.1524-475X.2009.00543.x 10.1016/S1349-0079(09)80024-8 10.1016/j.cytogfr.2014.07.016 10.4049/jimmunol.167.9.5067 |
ContentType | Journal Article |
Copyright | 2019 by the Wound Healing Society 2019 by the Wound Healing Society. |
Copyright_xml | – notice: 2019 by the Wound Healing Society – notice: 2019 by the Wound Healing Society. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1111/wrr.12743 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1524-475X |
EndPage | 660 |
ExternalDocumentID | 31287619 10_1111_wrr_12743 WRR12743 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Danish Council for Independent Research, Technology and Production funderid: 4005‐00029 – fundername: Danish Council for Independent Research, Technology and Production grantid: 4005-00029 |
GroupedDBID | --- .3N .GA .Y3 04C 05W 0R~ 10A 123 1OB 1OC 29R 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOJX ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS ECF ECT ECV EIHBH EJD EMB EMK EMOBN ENC EPT ESX EX3 F00 F01 F04 FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQ9 WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
ID | FETCH-LOGICAL-c3253-bc4abb30a7b419aa9c591ef95c1ceaca4ae3995ee143407404520ff18eca1fa63 |
IEDL.DBID | DR2 |
ISSN | 1067-1927 1524-475X |
IngestDate | Fri Jul 11 02:54:08 EDT 2025 Wed Feb 19 02:31:39 EST 2025 Thu Apr 24 22:53:11 EDT 2025 Tue Jul 01 03:01:38 EDT 2025 Wed Jan 22 16:38:02 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | 2019 by the Wound Healing Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3253-bc4abb30a7b419aa9c591ef95c1ceaca4ae3995ee143407404520ff18eca1fa63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3870-5113 0000-0003-0007-0335 |
PMID | 31287619 |
PQID | 2254516490 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2254516490 pubmed_primary_31287619 crossref_primary_10_1111_wrr_12743 crossref_citationtrail_10_1111_wrr_12743 wiley_primary_10_1111_wrr_12743_WRR12743 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November/December 2019 2019-11-00 2019-Nov 20191101 |
PublicationDateYYYYMMDD | 2019-11-01 |
PublicationDate_xml | – month: 11 year: 2019 text: November/December 2019 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States |
PublicationTitle | Wound repair and regeneration |
PublicationTitleAlternate | Wound Repair Regen |
PublicationYear | 2019 |
Publisher | John Wiley & Sons, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc |
References | 2002; 16 2019; 7 2015; 56 2001; 167 2015; 6 2015; 5 2015; 4 2013; 2 2017; 2017 2002; 50 2010; 17 2018; 101 2015; 10 1999; 24 2008; 15 2014; 25 2008; 3 2015; 5979 2011; 17 2012; 125 2013; 5 2003; 73 2018; 24 2013; 19 2017; 526 2010; 43 2018; 39 2009; 51 2018; 138 2013; 57 2013; 13 2017; 12 2005; 6 2011; 68 1997; 190 2012; 4 2014; 6 2014; 12 2007; 25 2014; 32 2012; 8 2001; 215 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 Field D (e_1_2_6_13_1) 2015; 5979 e_1_2_6_30_1 Harper D (e_1_2_6_2_1) 2014; 32 e_1_2_6_19_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_17_1 e_1_2_6_39_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_16_1 e_1_2_6_37_1 Müller U (e_1_2_6_46_1) 2008; 15 e_1_2_6_42_1 e_1_2_6_43_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_41_1 Mouritzen MV (e_1_2_6_18_1) 2018; 138 e_1_2_6_40_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_28_1 e_1_2_6_45_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – volume: 526 start-page: 244 year: 2017 end-page: 53 article-title: Interactions of the antimicrobial peptide nisin Z with conventional antibiotics and the use of nanostructured lipid carriers to enhance antimicrobial activity publication-title: Int J Pharm – volume: 2 start-page: 389 year: 2013 end-page: 99 article-title: Biofilms and inflammation in chronic wounds publication-title: Adv Wound Care – volume: 6 start-page: 1 year: 2014 end-page: 13 article-title: The M1 and M2 paradigm of macrophage activation: time for reassessment publication-title: F1000Prime Rep – volume: 6 start-page: 265sr6 year: 2014 article-title: Wound repair and regeneration: mechanisms, signaling, and translation publication-title: Sci Transl Med – volume: 4 start-page: 560 year: 2015 end-page: 82 article-title: Challenges in the treatment of chronic wounds publication-title: Adv Wound Care – volume: 56 start-page: 127 year: 2015 end-page: 38 article-title: Porcine models of cutaneous wound healing publication-title: ILAR J – volume: 4 start-page: 361 year: 2012 end-page: 70 article-title: Cationic host defence peptides: multifaceted role in immune modulation and inflammation publication-title: J Innate Immun – volume: 24 start-page: 1 year: 2018 end-page: 10 article-title: Neurotensin, substance P, and insulin enhance cell migration publication-title: J Pept Sci – volume: 167 start-page: 5067 year: 2001 end-page: 76 article-title: Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo publication-title: J Immunol – volume: 57 start-page: 3928 year: 2013 end-page: 35 article-title: Evaluation of a nisin‐eluting nanofiber scaffold to treat ‐induced skin infections in mice publication-title: Antimicrob Agents Chemother – volume: 12 start-page: 207 year: 2014 end-page: 18 article-title: Three‐dimensional cell culture systems and their applications in drug discovery and cell‐based biosensors publication-title: Assay Drug Dev Technol – volume: 138 start-page: 1 year: 2018 end-page: 6 article-title: Optimized scratch assay for in vitro testing of cell migration with an automated optical camera publication-title: J Vis Exp – volume: 3 start-page: 1101 year: 2008 end-page: 8 article-title: Analyzing real‐time PCR data by the comparative CT method publication-title: Nat Protoc – volume: 12 start-page: e0184164 year: 2017 article-title: Correction: differential regulation of innate immune cytokine production through pharmacological activation of nuclear factor‐erythroid‐2‐related factor 2 (NRF2) in burn patient immune cells and monocytes publication-title: PLoS One – volume: 68 start-page: 2161 year: 2011 end-page: 76 article-title: Multifunctional cationic host defence peptides and their clinical applications publication-title: Cell Mol Life Sci – volume: 10 start-page: 1 year: 2015 end-page: 20 article-title: Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival publication-title: PLoS One – volume: 39 start-page: 1 year: 2018 end-page: 14 article-title: Immunomodulation as rescue for chronic atonic skin wounds publication-title: Trends Immunol – volume: 17 start-page: 763 year: 2010 end-page: 71 article-title: Human skin wounds: a major Snoballing threat to public health and economy publication-title: Wound Repair Regen – volume: 6 start-page: 328 year: 2005 end-page: 40 article-title: The cornified envelope: a model of cell death in the skin publication-title: Nat Rev Mol Cell Biol – volume: 2017 start-page: 1 year: 2017 end-page: 12 article-title: HaCaT cells as a reliable in vitro differentiation model to dissect the inflammatory/repair response of human keratinocytes publication-title: Mediat Inflamm – volume: 17 start-page: 438 year: 2011 end-page: 44 article-title: Immunomodulatory efficacy of nisin‐a bacterial lantibiotic peptide publication-title: J Pept Sci – volume: 15 start-page: 21 year: 2008 end-page: 44 article-title: The innate immune system of mammals and insects publication-title: Contrib Microbiol – volume: 73 start-page: 713 year: 2003 end-page: 21 article-title: Essential involvement of IL‐6 in the skin wound‐healing process as evidenced by delayed wound healing in IL‐6‐deficient mice publication-title: J Leukoc Biol – volume: 7 start-page: 1 year: 2019 end-page: 9 article-title: Methods and challenges of using the Greater Wax Moth ( ) as a model organism in antimicrobial compound discovery publication-title: Microorganisms – volume: 5 start-page: 279 year: 2013 end-page: 86 article-title: The effects of continuous in vivo administration of Nisin on infection and immune response in mice publication-title: Probiot Antimicrob Proteins – volume: 190 start-page: 601 year: 1997 end-page: 11 article-title: Confocal laser scanning microscopy of porcine skin : implications for human wound healing studies publication-title: J Anat – volume: 43 start-page: 692 year: 2010 end-page: 702 article-title: The human cathelicidin LL‐37 preferentially promotes apoptosis of infected airway epithelium publication-title: Am J Respir Cell Mol Biol – volume: 19 start-page: 315 year: 2013 end-page: 27 article-title: Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory publication-title: Innate Immun – volume: 101 start-page: 135 year: 2018 end-page: 44 article-title: Induction by innate defence regulator peptide 1018 of pro‐angiogenic molecules and endothelial cell migration in a high glucose environment publication-title: Peptides – volume: 125 start-page: 3015 year: 2012 end-page: 24 article-title: Deconstructing the third dimension—how 3D culture microenvironments alter cellular cues publication-title: J Cell Sci – volume: 5979 start-page: 37 year: 2015 end-page: 41 article-title: Bioengineering of the model lantibiotic nisin publication-title: Bioengineered – volume: 24 start-page: 35 year: 1999 end-page: 42 article-title: Evaluation of immunomodulatory effects of nisin‐containing diets on mice publication-title: FEMS Immunol Med Microbiol – volume: 25 start-page: 453 year: 2014 end-page: 72 article-title: TNF and TNF‐receptors: from mediators of cell death and inflammation to therapeutic giants ‐ past, present and future publication-title: Cytokine Growth Factor Rev – volume: 215 start-page: 51 year: 2001 end-page: 6 article-title: Comparison of human skin or epidermis models with human and animal skin in in‐vitro percutaneous absorption publication-title: Int J Pharm – volume: 32 start-page: 445 year: 2014 end-page: 50 article-title: The physiology of wound healing publication-title: Surg (United Kingdom) – volume: 57 start-page: 5572 year: 2013 end-page: 9 article-title: Effects of bacteriocins on methicillin‐resistant biofilm publication-title: Antimicrob Agents Chemother – volume: 24 start-page: e3080 year: 2018 article-title: LL‐37 fragments have antimicrobial activity against biofilms and wound healing potential in HaCaT cell line publication-title: J Pept Sci – volume: 6 start-page: 1 year: 2015 end-page: 14 article-title: Antimicrobial nisin acts against saliva derived multi‐species biofilms without cytotoxicity to human oral cells publication-title: Front Microbiol – volume: 13 start-page: 23 year: 2013 article-title: In vivo activity of nisin A and nisin V against in mice publication-title: BMC Microbiol – volume: 50 start-page: 731 year: 2002 end-page: 4 article-title: Nisin, alone and combined with peptidoglycan‐modulating antibiotics: activity against methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant enterococci publication-title: J Antimicrob Chemother – volume: 16 start-page: 963 year: 2002 end-page: 74 article-title: Accelerated wound healing in tumor necrosis factor receptor p55‐deficient mice with reduced leukocyte infiltration publication-title: FASEB J – volume: 25 start-page: 467 year: 2007 end-page: 76 article-title: Keratinocyte cytokine and chemokine receptors publication-title: Dermatol Clin – volume: 5 start-page: 11458 year: 2015 article-title: Dynamic tensile forces drive collective cell migration through three‐dimensional extracellular matrices publication-title: Sci Rep – volume: 8 start-page: 231 year: 2012 end-page: 6 – volume: 51 start-page: 158 year: 2009 end-page: 64 article-title: Properties and applications of lantibiotics, a class of bacteriocins produced by gram‐positive bacteria publication-title: J Oral Biosci – ident: e_1_2_6_15_1 doi: 10.1128/AAC.00622-13 – ident: e_1_2_6_36_1 doi: 10.3892/etm.2011.402 – ident: e_1_2_6_31_1 doi: 10.1089/adt.2014.573 – ident: e_1_2_6_39_1 doi: 10.1089/wound.2012.0381 – ident: e_1_2_6_44_1 doi: 10.1016/S0378-5173(00)00665-7 – ident: e_1_2_6_32_1 doi: 10.1242/jcs.079509 – ident: e_1_2_6_19_1 doi: 10.1002/psc.3093 – ident: e_1_2_6_17_1 doi: 10.1007/s12602-013-9141-3 – ident: e_1_2_6_26_1 doi: 10.1016/j.ijpharm.2017.04.071 – ident: e_1_2_6_11_1 doi: 10.1002/psc.1341 – ident: e_1_2_6_21_1 doi: 10.1002/psc.3080 – ident: e_1_2_6_16_1 doi: 10.1016/S0928-8244(99)00004-8 – ident: e_1_2_6_22_1 doi: 10.3390/microorganisms7030085 – volume: 32 start-page: 445 year: 2014 ident: e_1_2_6_2_1 article-title: The physiology of wound healing publication-title: Surg (United Kingdom) – ident: e_1_2_6_10_1 doi: 10.1007/s00018-011-0710-x – ident: e_1_2_6_42_1 doi: 10.12703/P6-13 – ident: e_1_2_6_30_1 doi: 10.1155/2017/7435621 – ident: e_1_2_6_45_1 doi: 10.1093/ilar/ilv016 – ident: e_1_2_6_23_1 doi: 10.3389/fmicb.2015.00617 – volume: 15 start-page: 21 year: 2008 ident: e_1_2_6_46_1 article-title: The innate immune system of mammals and insects publication-title: Contrib Microbiol – ident: e_1_2_6_43_1 doi: 10.1046/j.1469-7580.1997.19040601.x – ident: e_1_2_6_20_1 doi: 10.1038/nprot.2008.73 – ident: e_1_2_6_29_1 doi: 10.1038/nrm1619 – ident: e_1_2_6_3_1 doi: 10.1016/j.it.2018.01.010 – ident: e_1_2_6_28_1 doi: 10.1186/1471-2180-13-23 – ident: e_1_2_6_14_1 doi: 10.1128/AAC.00888-13 – volume: 138 start-page: 1 year: 2018 ident: e_1_2_6_18_1 article-title: Optimized scratch assay for in vitro testing of cell migration with an automated optical camera publication-title: J Vis Exp – ident: e_1_2_6_7_1 doi: 10.1165/rcmb.2009-0250OC – ident: e_1_2_6_6_1 doi: 10.1159/000336630 – ident: e_1_2_6_35_1 doi: 10.1189/jlb.0802397 – ident: e_1_2_6_5_1 doi: 10.1126/scitranslmed.3009337 – volume: 5979 start-page: 37 year: 2015 ident: e_1_2_6_13_1 article-title: Bioengineering of the model lantibiotic nisin publication-title: Bioengineered – ident: e_1_2_6_4_1 doi: 10.1016/j.det.2007.06.003 – ident: e_1_2_6_9_1 doi: 10.1089/wound.2015.0635 – ident: e_1_2_6_25_1 doi: 10.1093/jac/dkf190 – ident: e_1_2_6_37_1 doi: 10.1016/j.peptides.2018.01.010 – ident: e_1_2_6_33_1 doi: 10.1038/srep11458 – ident: e_1_2_6_40_1 doi: 10.1096/fj.01-0776com – ident: e_1_2_6_34_1 doi: 10.1371/journal.pone.0184164 – ident: e_1_2_6_27_1 doi: 10.1371/journal.pone.0131008 – ident: e_1_2_6_8_1 doi: 10.1177/1753425912461456 – ident: e_1_2_6_24_1 doi: 10.1111/j.1524-475X.2009.00543.x – ident: e_1_2_6_12_1 doi: 10.1016/S1349-0079(09)80024-8 – ident: e_1_2_6_38_1 doi: 10.1016/j.cytogfr.2014.07.016 – ident: e_1_2_6_41_1 doi: 10.4049/jimmunol.167.9.5067 |
SSID | ssj0005598 |
Score | 2.4606729 |
Snippet | Antimicrobial peptides can have a dual role with both antimicrobial activity against a broad range of bacteria and immunomodulatory effect, making them... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 650 |
Title | Immunomodulatory potential of Nisin A with application in wound healing |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fwrr.12743 https://www.ncbi.nlm.nih.gov/pubmed/31287619 https://www.proquest.com/docview/2254516490 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF6KJy8-8FVfrOLBS0q22aQNnopaq2APxWIPQtjd7kJRk5K2FP31zmwetj5APCWEyWazszPz7esbQs6URH9YHzpMNYTDfeM7oZG4R0wMpVRNoyyZzn036PT53cAfVMhFcRYm44coJ9zQMqy_RgMXcrJg5PM0rTEYUyHTJ_MC5M2_6n1SRyHxuF3pBEcAKKaRswrhLp7yzeVY9A1gLuNVG3Da6-SpqGq2z-S5NpvKmnr_wuL4z3_ZIGs5EKWtrOdskoqOt8jNLR4XSV6TIWb1StI3Ok6muJ8IJBNDu6PJKKYtipO3dGHpm8LTOeZnoog7IRhuk377-uGy4-SpFhzl1X3PkYoLKT1XNCRnoRCh8kOmTegrpsA1Cy40noHVGuAVDAE5ErG7xrCmVoIZEXg7ZCVOYr1HKIyPAsWE6xtuOPQEULfRdUAWrivg6lbJedHokcp5yDEdxktUjEegNSLbGlVyWoqOM_KNn4ROCs1FYBq43iFincwmEbgqTEPMQ_jmbqbSshgP4jLO4EBtrGJ-Lz967PXszf7fRQ_IKgCrMDuzeEhWpulMHwF4mcpj20s_ADDn67s |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT8IwFG8QD3rxI37hZzUevIxsrAOWeCFGBAUOBCIXs7SlTYi6ERgh-tf7XscQ_EiMpy1L13V9fa-_tu_9HiGXUqA9LPQtR5a4xTztWb4W6CPG-0LIspaGTKfZKta67L7n9TLkOo2FSfgh5htuqBnGXqOC44b0gpZPR6O8A4sqd4WsmvM5hETtT_IopB43Z51gCgDHlGa8QujHM391eTb6BjGXEauZcqqb5CltbOJp8pyfxCIv37_wOP73b7bIxgyL0koyeLZJRoU75K6OESPRa9THxF7R6I0OoxhdiqBkpGlrMB6EtEJx_5YunH5TeDrFFE0UoSfMh7ukW73t3NSsWbYFS7oFz7WEZFwI1-YlwRyfc196vqO070lHgnXmjCsMg1UKEBasAhlysdtaO2UluaN50d0j2TAK1QGhsEQqSofbnmaawWAAiWtVAHBh2xyudo5cpb0eyBkVOWbEeAnSJQn0RmB6I0cu5kWHCf_GT4XOU9EFoB145MFDFU3GAVgrzETMfPjmfiLTeTUuTM24iQOtMZL5vf7gsd02N4d_L3pG1mqdZiNo1FsPR2QdcJafhDAek2w8mqgTwDKxODVD9gPwFu_Z |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA5zgvjiBW_zGsUHXzqaNd1WfBrqnLchw-EehJJkCQy1HV3H0F_vOe06Ny8gPrWU0zRNcs75Ti7fIeRYSbSHpa7FVEVY3DWu5RmJe8REV0pVNSoh07lrlhttft1xOzlymp2FSfkhJhNuqBmJvUYF73fNlJKPoqjIIKZy5sg8L4ObRETU-uSOQubxZKkTLAHAmMqYVgi38UxenXVG3xDmLGBNPE59mTxldU03mjwXh7EsqvcvNI7__JkVsjRGorSWDp1VktPBGrm8wvMi4WvYxbReYfRG-2GMG4pAMjS02Rv0AlqjOHtLp9a-KTwdYYImisATvOE6adcvHs4a1jjXgqWckutYUnEhpWOLiuTME8JTrse08VzFFNhmwYXGQ7BaA76CGJAjE7ttDKtqJZgRZWeD5IMw0FuEQoBUVkzYruGGw1CA_ja6BNDCtgVc7QI5yRrdV2MicsyH8eJnAQm0hp-0RoEcTUT7KfvGT0KHWc_5oBu44CECHQ4HPtgqzEPMPfjmZtqlk2IccMw4hQO1STrm9_L9x1Yrudn-u-gBWbg_r_u3V82bHbIIIMtLzy_uknwcDfUeAJlY7icD9gM2te6I |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunomodulatory+potential+of+Nisin+A+with+application+in+wound+healing&rft.jtitle=Wound+repair+and+regeneration&rft.au=Mouritzen%2C+Michelle+V.&rft.au=Andrea%2C+Athina&rft.au=Qvist%2C+Katrine&rft.au=Poulsen%2C+Steen+S.&rft.date=2019-11-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1067-1927&rft.eissn=1524-475X&rft.volume=27&rft.issue=6&rft.spage=650&rft.epage=660&rft_id=info:doi/10.1111%2Fwrr.12743&rft.externalDBID=10.1111%252Fwrr.12743&rft.externalDocID=WRR12743 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1067-1927&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1067-1927&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1067-1927&client=summon |